Duke Heart Failure Symposium 2025

June 7, 2025

A variety of recent developments in the field of heart failure (HF) therapies, including novel drugs, new devices, and care innovations inform the current effort to improve HF education and refine approaches to disease management for clinicians. Physicians and other practitioners must be armed with the most up-to-date evidence to guide best treatments and improve the prognosis for patients with HF. Thus, it is critically important to raise awareness and improve knowledge about the symptoms, diagnosis, therapeutic options, and outcomes in HF. The symposium will address issues such as diagnosing and managing HFrEF & HFpEF, remote patient monitoring, cardiomyopathies, care transitions, interventional and device management, cardiometabolic care, advanced HF management, in addition to quality of life and patient preferences; our local and invited keynote speakers will incorporate case-based lectures, panel discussions and Q&A into the symposium to further address these critical issues.

Target Audience

Allied Health Professionals

Fellows

Nurses

Nurse Practitioners

Physicians

Physician Assistants

Pharmacists

Residents

Learning Objectives

1. Recognizing  current treatment strategies for chronic heart failure with reduced ejection fraction (HFrEF), including emerging pharmacologic therapies, updated treatment paradigms, and associated challenges.

2. Reviewing and discuss best practices for diagnosing and managing heart failure with preserved ejection fraction (HFpEF).

3. Discussing diagnostic and treatment strategies for different cardiomyopathies, aiming to enhance clinical outcomes and disease trajectory. Raise awareness about precision cardiomyopathy programs.

4. Recognizing challenges during care transitions and discuss multidisciplinary strategies for enhancing care coordination, including considerations for costs and access to new heart failure medications and strategies for follow-up care.

5. Discussing the role of interventional and device management in acute and chronic heart failure.

6. Discussing the current practices to assess and track congestion status. Review methods current best practices for remote monitoring.

7. Discussing he changing landscape of cardiometabolic care including anti-diabetic and weight loss management.

8. Reviewing and discuss best practices for consideration of quality of life and patient preferences for patients living with heart failure.

9. Discussing navigation of a worsening heart failure event including optimal timing of workup for advanced heart failure therapies. Review current standards in advanced heart failure management.

Course summary
Available credit: 
  • 5.00 ACPE - Pharmacist
  • 5.00 AMA PRA Category 1 Credit(s)™
  • 5.00 ANCC
  • 5.00 Attendance
  • 0.50 IACET CEU
  • 5.00 JA Credit - AH
    • 4.50 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
06/07/2025
Registration Expires: 
06/06/2026
Activity Starts: 
06/07/2025 - 8:30am EDT
Activity Ends: 
06/07/2025 - 3:45pm EDT
Add to calendar: 
Rating: 
0

Stephanie Barnes, NP

Patrick McCann, MD

Jason Guichard, MD

Patricia Chang, MD

John Rommel, MD

Sam Sears, MD

Elizabeth Volz, MD

Stephen Greene, MD

Oksana Kamneva, PharmD

Senthil Selvaraj, MD

Carolyn Lekavich, PhD, ANP-C

Karen Flores Rosario, MD

Michel Khouri, MD

Ravi Karra, MD

Aferdita Spahillari, MD

Margaret Bowers, DNP

Imran Aslam, MD

Andres Pineda Maldonado, MD

G. Michael Felker, MD

Todd McVeigh, PA

Stuart Russell, MD

Jeffrey Keenan, MD

Phoenix Grover, CGC (genetics counselor)

Laura Blue, DNP

Adam DeVore, MD

Vishal Rao, MD

Carlos Santos-Gallego, MD

Josephine Harrington, MD

 

ACPE - Pharmacist

AMA PRA Category 1 Credit(s)

ANCC

Attendance

IACET CEU

Available Credit

  • 5.00 ACPE - Pharmacist
  • 5.00 AMA PRA Category 1 Credit(s)™
  • 5.00 ANCC
  • 5.00 Attendance
  • 0.50 IACET CEU
  • 5.00 JA Credit - AH
    • 4.50 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.